Results for tag: "Darzalex"

Darzalex is a monoclonal antibody drug used in the treatment of multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow. It is used in combination with other drugs to treat patients who have received at least one prior therapy. Darzalex works by targeting a protein called CD38, which is found on the surface of multiple myeloma cells. This helps to slow down the growth of the cancer cells and can even lead to their destruction. Darzalex is administered intravenously and is available in both injection and infusion forms. Darzalex is a relatively new drug, having been approved by the US Food and Drug Administration in 2015. It has since become a popular treatment option for multiple myeloma patients, as it has been shown to be effective in slowing the progression of the disease. The Darzalex market is highly competitive, with several companies offering the drug. These include Janssen Biotech, Inc., Genmab, Amgen, and Bristol-Myers Squibb. Each of these companies has its own unique approach to the drug, with some offering different formulations and delivery methods. Show Less Read more